Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces

Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces

BACKGROUND Confidential product listing agreements (PLAs) negotiated between pharmaceutical manufacturers and individual health care payers may contribute to unwanted price disparities, high administrative costs, and unequal bargaining power within and across jurisdictions. In the context of Canada's decentralized health system, we aimed to document provincial policy makers' perceptions about c...

Author's response to reviews Title: Inter-jurisdictional cooperation on pharmaceutical product listing agreements: lessons from Canada Authors:

Product listing agreements (PLAs): a new tool for reaching Quebec's pharmaceutical policy objectives?

Product listing agreements (PLAs) with pharmaceutical manufacturers are increasingly viewed as an innovative and useful tool in the effort to control drug expenditures. To date, Quebec is the only province that has been reluctant to enter into such agreements, arguing that their confidential nature may lead to a disparity in coverage between individuals covered by the public plan and those cove...

Evaluation of Inter-jurisdictional Cooperation Strategies for Atms/atis Deployment

Filippo Logi Fachgebiet Verkehrstechnick und Verkehrsplanung, Munich University of Technology Arcisstrasse 21, 80290 Munich, Germany Tel: (49) 89 289 2569 Fax (49) 89 289 23840 e-mail: [email protected] Stephen G. Ritchie Institute of Transportation Studies, University of California, Irvine Irvine, CA, 92697-3600, USA Tel: (1) 949 824 4214 Fax (1) 949 824 8385 e-mail: [email protected] Michael G. ...

Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

OBJECTIVES To address the uncertainty associated with procuring pharmaceutical products, product listing agreements (PLAs) are increasingly being used to support responsible funding decisions in Canada and elsewhere. These agreements typically involve financial-based rebating initiatives or, less frequently, outcome-based contracts. A qualitative survey was conducted to improve the understandin...